Best Treatment for IBS When Nothing Else Works: The Honest Refractory IBS Map (2026)
You have tried low-FODMAP. You have tried antispasmodics, peppermint oil, soluble fiber, probably Nerva. None of it stuck. This is not a 'one more thing to try' article. This is the honest, evidence-based map of every serious option for refractory IBS, sequenced by risk and intervention level, with gut-directed hypnotherapy placed exactly where NICE places it: second-line for refractory cases.
The short answer
When standard IBS treatment fails, the honest map has four steps in order: (1) Re-evaluate the diagnosis with a gastroenterologist, because some 'refractory IBS' is actually missed bile acid malabsorption, celiac, MCAS, or pelvic floor dysfunction. (2) Consider prescription escalation (rifaximin, eluxadoline, lubiprostone, linaclotide), each indicated for a specific subtype. (3) Try brain-gut behavioral therapy (CBT for IBS, gut-directed hypnotherapy, mindfulness-based therapy), all NICE-endorsed for refractory cases. (4) Layer integrative support (RDN-supervised low-FODMAP if not done properly, sleep, exercise). Gut-directed hypnotherapy fits in Step 3 with NICE and ACG backing, but it is one option, not the only one.
Key takeaways
- Refractory IBS is a real category: NICE CG61 and ACG 2021 both define refractory IBS as a distinct clinical entity with a defined treatment ladder. You meeting the definition is not personal failure, it is the start of a sequenced escalation, not the end of options.
- Step 1 is always GI re-evaluation: Roughly 30% of refractory IBS-D patients have unrecognized bile acid malabsorption. Microscopic colitis, pelvic floor dysfunction, MCAS, celiac, and endometriosis are commonly missed. Re-evaluate before climbing the ladder.
- GDH = NICE-endorsed Step 3: Gut-directed hypnotherapy is NICE-endorsed second-line for refractory IBS, alongside CBT-IBS and mindfulness. Moser 2013 RCT showed 40% response in refractory patients (vs 13% control). ARCH-credentialed clinicians $220 to $350 per session.
- Completion beats variety: The biggest predictor of success is completing a full protocol of one therapy. Two full protocols of two therapies in sequence outperform five half-protocols of five things. Pick what you will finish, commit.
If you are reading this, you are probably exhausted. You have tried low-FODMAP for three or six months, maybe with a dietitian, maybe alone. You have tried peppermint oil capsules, soluble fiber, antispasmodics, probiotics, maybe Nerva or a similar app. You have read enough Reddit threads to recognize half the usernames. Nothing has worked, or nothing has worked for long enough to count. I run a gut-directed hypnotherapy practice, so the easy thing for me to do here would be to tell you that hypnotherapy is the answer. The honest thing is to tell you that the answer to 'what works when nothing else does' is a sequenced escalation, not a single product. Gut-directed hypnotherapy is one of the options on that ladder, and a well-supported one (NICE-endorsed, ACG-endorsed, with refractory-population RCT data from Moser 2013 specifically). It is not the first step. The first step, for almost everyone reading this, is going back to a gastroenterologist and re-checking whether the diagnosis is correct.
About 40% of refractory IBS patients respond to gut-directed hypnotherapy in the Moser 2013 RCT
Moser et al published a randomized controlled trial in 2013 (American Journal of Gastroenterology) that is uniquely relevant to anyone reading this article. The trial specifically enrolled IBS patients who had failed prior conventional treatment. The hypnotherapy arm hit clinically meaningful improvement in roughly 40% of patients versus 13% in the supportive talk therapy arm. The follow-up at 12 months held. This is not the only evidence base for gut-directed hypnotherapy, but it is the most relevant one for refractory IBS because the trial population looks like the population reading this. Two honest reads on the Moser data. First, gut-directed hypnotherapy genuinely works in refractory IBS more often than not-working, which is why NICE and ACG list it as a recommended second-line intervention. Second, it still leaves roughly 60% of refractory patients without meaningful response, which is why this article puts diagnostic re-evaluation first and treats hypnotherapy as one option in a sequence rather than the answer. If your prior treatment failures included a fixed-script app like Nerva, that is not the same thing as having failed clinician-led, personalized hypnotherapy. But if you have already tried clinician-led hypnotherapy with no response, the next step is something else on the ladder, not more hypnotherapy.
What 'refractory IBS' actually means (and why you might or might not be it)
Refractory IBS is not a vibe. It is a clinical category with a working definition, and the definition matters because it changes what comes next.
The commonly accepted working definition: IBS symptoms that persist despite an adequate trial of first-line treatment, where 'adequate' means at least 6 to 12 weeks of properly structured intervention. NICE CG61 (the UK guideline, updated 2017 and reaffirmed since) uses 'continuing symptoms after 12 months' as the trigger for considering psychological therapies. ACG 2021 (American College of Gastroenterology guideline) defines refractory IBS more loosely as failure of first-line dietary and pharmacological intervention.
What counts as 'first-line' that you should have already done properly: a structured low-FODMAP trial (ideally with a registered dietitian, full elimination followed by structured reintroduction, not just 'I cut out gluten and dairy for a while'), at least one antispasmodic trial (hyoscine, mebeverine, peppermint oil enteric-coated capsules), soluble fiber for IBS-C or loperamide for IBS-D, and basic lifestyle work (sleep, exercise, alcohol reduction). If you have not actually completed a properly structured low-FODMAP elimination and reintroduction with an RDN, you are not refractory yet. You are under-treated.
What does not count as a refractory trial: trying a probiotic for two weeks. Cutting out gluten without a celiac workup first. Buying a $30 supplement off Instagram. Downloading an IBS app and using it for a month. Doing low-FODMAP from a blog post without reintroduction. These are common, and they are not refractory failures. If any of those describes your prior 'treatment history', the right step is to do the real version of the first-line work before climbing the escalation ladder.
If you have genuinely done the first-line work properly and your symptoms are still significantly affecting your life, you meet the working definition and the rest of this article is for you. If you have not, save yourself the escalation and do the foundational work properly first. A few months with a good RDN will outperform almost everything in Step 3 for people who never actually completed structured low-FODMAP.
Step 1: Re-evaluate the diagnosis (because sometimes refractory IBS isn't IBS)
This is the step almost every article skips and almost every patient skips. It is the most important one.
IBS is a diagnosis of exclusion, made by Rome IV criteria after ruling out organic disease. The Rome IV criteria require recurrent abdominal pain at least one day per week in the last three months, associated with two or more of: related to defecation, change in stool frequency, or change in stool form. Pain plus bowel-habit change is the core. If your symptoms do not fit that pattern, the diagnosis may have been wrong from the start.
What to ask a gastroenterologist to revisit, especially if it has been more than two years since your original workup:
Bile acid malabsorption (BAM). Affects roughly 30% of patients labeled IBS-D. Standard test is SeHCAT in the UK and Europe; less available in North America where the workup is often a therapeutic trial of cholestyramine or colesevelam. If you have IBS-D and have never been screened or trialed for BAM, that is a major gap.
Microscopic colitis. Looks like IBS-D but visible only on random colonic biopsy, not standard colonoscopy gross inspection. If your prior colonoscopy did not include random biopsies and you have chronic watery diarrhea, this is worth revisiting.
Celiac disease. Even with prior negative serology, retesting is reasonable if you have been eating wheat regularly and symptoms have changed. Some celiac is seronegative and requires biopsy.
Small intestinal bacterial overgrowth (SIBO). Lactulose or glucose breath test. Controversial in how often it actually drives IBS symptoms, but a real entity in a subset of patients and missing it changes management.
Pelvic floor dysfunction. Especially in IBS-C with sensation of incomplete evacuation, straining, or digital maneuvers. Anorectal manometry and balloon expulsion testing diagnose it. Pelvic floor physical therapy is the treatment, not laxatives. This is genuinely common and genuinely missed.
Mast cell activation syndrome (MCAS). Controversial diagnostic territory, but worth considering if your gut symptoms come with flushing, urticaria, anaphylactoid reactions, or fragrance/temperature sensitivities. We have a separate article on this at could my IBS actually be MCAS.
Endometriosis. In anyone with a uterus, especially if symptoms track the menstrual cycle. Pelvic endometriosis frequently presents as 'IBS' for years before being recognized.
Chronic giardiasis or other parasitic. Especially if symptoms started after travel, well water exposure, or a known GI infection.
The pattern: refractory IBS that doesn't respond to anything is sometimes a different diagnosis that responds well to its actual treatment. Asking your GI for a focused re-evaluation is not a sign you are being difficult. It is the standard of care for anyone meeting the refractory definition. If your current GI dismisses the request, getting a second opinion at an academic GI center with a functional GI program (Mayo, Cleveland Clinic, Toronto Western, University of Calgary GI, etc.) is reasonable.
Step 2: Prescription escalation (what each medication actually does)
Once diagnosis is confirmed and first-line work is genuinely done, the next ladder rung is prescription medication targeted to your subtype. I cannot prescribe any of these. Your GP or gastroenterologist does. The point of this section is so you can have an informed conversation about which is appropriate.
Rifaximin (Xifaxan). Non-absorbed antibiotic. FDA-approved for IBS-D. Typical course is 550mg three times daily for 14 days. Mechanism is thought to modulate small intestinal microbiota. Response rate in IBS-D is roughly 40 to 45% in the TARGET 3 trials, with sustained response in a subset. Often used when SIBO is suspected or confirmed. Re-treatment is possible if symptoms recur. Covered by most insurance with prior authorization. We have a separate article comparing hypnotherapy vs rifaximin for SIBO if your situation specifically involves SIBO overlap.
Eluxadoline (Viberzi). Mixed mu-opioid receptor agonist and delta-opioid receptor antagonist. FDA-approved for IBS-D. Daily medication. Contraindicated in patients without a gallbladder due to pancreatitis risk. Used when rifaximin has failed or is not appropriate. Response rate in pivotal trials roughly 25 to 30% for the composite endpoint.
Lubiprostone (Amitiza). Chloride channel activator that increases intestinal fluid secretion. Approved for IBS-C in women. Daily medication. Common side effect is nausea, which is dose-related.
Linaclotide (Linzess) and plecanatide (Trulance). Guanylate cyclase-C agonists. Approved for IBS-C and chronic idiopathic constipation. Daily medication. Increase intestinal fluid and accelerate transit. Diarrhea is the common dose-limiting side effect. Often the most effective prescription option for IBS-C.
Tenapanor (Ibsrela). NHE3 inhibitor. Newer IBS-C option. Different mechanism from the guanylate cyclase agonists, so worth trying if those failed or were not tolerated.
Tricyclic antidepressants (low-dose amitriptyline, nortriptyline, desipramine). Used as 'neuromodulators' for visceral pain at much lower doses than antidepressant dosing (typically 10 to 50mg). The ACG 2021 guideline gives a strong recommendation for tricyclics in IBS based on the ATLANTIS trial. Side effect profile (anticholinergic, sedation) is the main barrier. Often the best option when pain is the dominant symptom regardless of subtype.
SSRIs and SNRIs. Less consistent IBS-specific evidence than tricyclics. Sometimes used when depression or anxiety is a major comorbidity and treating the upstream condition helps the gut.
The honest read on prescription escalation: none of these is a cure. Each works in roughly 25 to 45% of appropriate patients, and effects often diminish over time or with discontinuation. The right one depends on your subtype, prior trials, and tolerance. A gastroenterologist who treats IBS regularly should be willing to systematically work through the appropriate ones rather than declaring you a treatment failure after one try.
Rifaximin (TARGET 3): ~40 to 45% in IBS-D. Eluxadoline: ~25 to 30%. Linaclotide and similar in IBS-C: ~35 to 45%. Tricyclics for pain-predominant: meaningful effect (ACG 2021 strong recommendation). The pattern: none is a cure, all are partial, the second or third trial often works when the first did not.
Source: TARGET 3 trials; ACG 2021 IBS Clinical Practice Guideline; Lacy et al American Journal of Gastroenterology 2021
Step 3: Brain-gut behavioral therapies (CBT, hypnotherapy, mindfulness)
This is where I have an obvious conflict of interest, so I am going to be especially careful to describe the three main options honestly rather than steer you toward mine.
Cognitive Behavioral Therapy for IBS (CBT-IBS). The most studied behavioral therapy for IBS. The 2019 ACTIB trial (Everitt et al, Gut journal) is the landmark recent study. ACTIB compared telephone-delivered CBT, web-based CBT (Regul8), and treatment as usual in 558 refractory IBS patients. Both CBT arms produced significant symptom improvement that held at 24 months. Effect sizes were moderate, response rates roughly 50 to 60% for clinically meaningful improvement. CBT-IBS is a specialized form of CBT focused on the gut-brain axis, not generic anxiety CBT. The work targets symptom-related thoughts, hypervigilance, behavioral avoidance, and stress management. Often delivered in 8 to 12 sessions. Available virtually. Often coverable by extended health benefits because the providers are typically registered psychologists. If you have psychology coverage and have not tried CBT-IBS specifically (not generic anxiety CBT), this is a strong option.
Gut-directed hypnotherapy (GDH). The work I do. NICE-endorsed for refractory IBS (CG61). Evidence base traces back through Whorwell's Manchester Protocol work (1980s onward, sustained response rates 70 to 80% in clinical populations), Palsson's North Carolina Protocol (2002), Peters et al's 2016 RCT showing GDH comparable to low-FODMAP, and the Moser 2013 RCT specifically in refractory IBS (40% response in hypnotherapy versus 13% in control). Standard delivery is 6 to 12 weekly sessions following Manchester or North Carolina Protocol. Available virtually. Generally not covered by extended health benefits in Canada. ARCH-credentialed gut-specialized clinicians charge $220 to $350 per session. The mechanism is thought to target visceral hypersensitivity, autonomic regulation, and the gut-brain axis directly, with effects independent of mood improvement.
Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT). Smaller evidence base in IBS specifically than CBT or GDH, but a few decent trials (Gaylord 2011, Zernicke 2013) show moderate improvement in IBS symptoms and quality of life. Often delivered in 8-week group format. Often free or low-cost through hospital pain programs or community offerings. Reasonable option if CBT-IBS and GDH are not accessible or affordable.
How to choose among the three. All three are NICE and ACG endorsed for refractory IBS. None is clearly superior in head-to-head trials (Flik 2019 compared GDH versus 'gut-focused education' rather than CBT, so a true CBT vs GDH head-to-head trial still doesn't exist). Practical decision factors: CBT-IBS if you have psychology coverage and want a more cognitive-behavioral framework. GDH if you have tried CBT and it did not click, if your symptoms have a strong visceral hypersensitivity component (pain out of proportion to triggers), or if you want a different mechanism than cognitive restructuring. MBSR/MBCT if cost or access is the dominant factor. Best outcome is usually achieved by completing one full protocol of one therapy properly, not jumping between them. We have a deeper comparison at gut-directed hypnotherapy vs CBT for IBS.
CBT for IBS, gut-directed hypnotherapy, and mindfulness-based therapy are all listed as appropriate second-line options for refractory IBS in the major guidelines. None is clearly superior to another in head-to-head trials. The biggest single predictor of outcome is completion of a full protocol of one therapy, not jumping between three.
Source: NICE CG61 (UK, updated 2017); ACG 2021 IBS Clinical Practice Guideline; Everitt ACTIB 2019 Gut; Moser 2013 American Journal of Gastroenterology
Step 4: Integrative add-ons (dietitian, sleep, exercise, the foundational layer)
These are not 'last resort' options. They are the foundational layer that should run alongside whatever you do in Steps 2 and 3.
Registered dietitian supervised low-FODMAP. If your prior low-FODMAP attempt was self-directed from a blog post, you have not actually done it. A proper trial is structured elimination for 2 to 6 weeks, careful symptom tracking, then systematic reintroduction of each FODMAP group to identify your specific triggers. The Peters 2016 RCT showed structured low-FODMAP performed comparably to gut-directed hypnotherapy. The catch is that 'structured' is doing real work in that sentence. A dietitian with monash low-FODMAP training is the standard. If you do not have one and cannot afford one, the Monash University low-FODMAP app is the next best thing.
Sleep. Poor sleep amplifies visceral hypersensitivity. The literature on sleep and IBS is consistent that disrupted sleep predicts worse symptoms the next day. Sleep work is not optional in refractory cases. Sleep apnea screening is reasonable if symptoms include morning headaches, daytime fatigue, or you snore.
Exercise. Moderate aerobic exercise (walking, cycling, swimming) 30 minutes most days improves IBS symptoms in multiple trials (Johannesson 2011, 2015). The effect is real and dose-dependent. This is not a vague wellness recommendation, it is a specific intervention with RCT evidence.
Alcohol reduction or elimination. Alcohol is a direct gut irritant and a sleep disruptor. Many refractory IBS patients underestimate how much their occasional drinking affects symptoms. A two-month abstinence trial is informative.
Psychiatric care if depression, anxiety, or trauma is significant. Treating the upstream mental health condition often helps the gut. This is not 'your IBS is in your head', it is gut-brain axis pharmacology. If acute depression or panic disorder is untreated, behavioral gut therapies will work poorly.
Avoid the rabbit hole of supplements. Probiotics have weak and strain-specific evidence; some formulations have a small benefit but the supplement market is mostly noise. Glutamine, butyrate, berberine, and similar are mostly low-quality evidence. Spending money on supplements is rarely the missing piece in refractory IBS, and the time and attention spent researching them is usually better spent on Steps 1 through 3.
Where gut-directed hypnotherapy specifically fits (NICE-endorsed for refractory)
I have spent five sections trying to be honest about the rest of the ladder. Here is the part where I describe what I actually do, with the conflict openly declared.
Where GDH sits in the formal guidelines. NICE CG61 (UK guideline on IBS, originally 2008, updated 2017) explicitly recommends hypnotherapy as a second-line option for IBS that has not responded to first-line pharmacological treatment after 12 months. The ACG 2021 guideline gives a conditional recommendation for gut-directed psychotherapies including hypnotherapy in IBS, with moderate-quality evidence. The Rome IV multidimensional clinical profile lists psychological therapies including GDH as appropriate for moderate to severe IBS. This is not a fringe placement. It is standard-of-care second-line in two of the three major IBS guidelines.
The refractory-specific evidence. The Moser 2013 RCT is the most relevant single trial. It enrolled IBS patients who had failed prior conventional treatment (the population reading this), randomized them to gut-directed hypnotherapy or supportive talk therapy, and found 40% clinically meaningful improvement in the hypnotherapy arm versus 13% in the control arm. The 12-month follow-up held. This is a meaningful effect size in a refractory population. We have a full breakdown at Moser 2013 Vienna RCT breakdown. The Whorwell Manchester Protocol papers (going back to 1984, with 30-year follow-up by Lindfors 2012) show sustained response rates in the 70 to 80% range in clinic populations, though clinic data is more favorable than RCT data because it selects for people who completed treatment.
What gut-directed hypnotherapy actually is. A structured protocol (Manchester Protocol or North Carolina Protocol are the two main lineages) delivered over 6 to 12 weekly sessions. The work uses suggestion, visualization, and direct targeting of the gut-brain axis to reduce visceral hypersensitivity, regulate autonomic tone, and reduce symptom-related hypervigilance. It is not generic relaxation. It is not stage hypnosis. It is a clinical protocol with specific session structures, between-session audio practice, and outcome tracking. It is voluntary, not mind control, and it does not work if you are not committed to the practice between sessions.
Where GDH wins for refractory IBS. Different mechanism from CBT (suggestion and visceral targeting rather than cognitive restructuring), so worth trying if CBT did not click. Different mechanism from prescriptions, so worth adding rather than replacing if you have partial pharmacological response. Sustained effects in the literature (Moser 12-month follow-up, Lindfors 30-year follow-up data) suggest the work persists after the protocol ends, unlike medications which often require continuation. No drug interactions, no contraindications for most patients (active dissociation or severe untreated psychiatric illness are the exceptions).
Where GDH loses. Cost is substantial ($1,320 to $2,800 for a full clinician-led protocol). Not covered by Canadian provincial plans or most extended health benefit plans. Requires consistent between-session practice, which is hard when you are exhausted. Roughly 60% of refractory patients in the Moser trial did not hit the response threshold, so it is not a guaranteed win. Apps deliver a fixed-script version cheaper ($199/year for Nerva) but with much lower completion rates (~9% per Peters 2023) and no personalization.
Insurance honest section. Hypnotherapy isn't directly covered by Canadian provincial health plans or most extended health benefit plans. Hypnotherapy isn't a regulated profession in Alberta. Some clients get reimbursement through their employer's Wellness Spending Account (WSA) under categories like 'stress management' or 'mental wellness'. WSAs are different from Health Spending Accounts (HSAs), which follow strict CRA medical-expense rules that exclude practitioners who aren't on a provincial regulated list. Always check with your specific plan whether RCH services qualify.
The ARCH credential. Calgary Gut Hypnotherapy is ARCH-credentialed. ARCH (Association of Registered Clinical Hypnotherapists of Canada) is the most stringent voluntary professional body for clinical hypnotherapy in Canada. Membership requires documented training hours, supervised practice, and adherence to a code of ethics. Hypnotherapy is not a regulated profession in any Canadian province, so anyone can use the title 'hypnotherapist'. ARCH membership is the closest meaningful credential.
Pricing. $220 to $350 per session depending on complexity. 3-session commitment $660 to $1,050. Full 6 to 8 session protocol $1,320 to $2,800. Virtual across Canada or in person in Calgary.
The Moser RCT is the single most relevant trial for anyone reading this article because it specifically enrolled IBS patients who had failed prior conventional treatment. The effect held at 12 months. Roughly 60% of refractory patients still did not hit the response threshold, which is why GDH is one option in the Step 3 bucket rather than the answer.
Source: Moser G et al, American Journal of Gastroenterology 2013; 12-month follow-up published 2013
| Step | What It Targets | Cost (CAD) | Timeline | Evidence Strength | Best For |
|---|---|---|---|---|---|
| Step 1: GI re-evaluation | Missed alternative diagnoses (BAM, microscopic colitis, pelvic floor, celiac, endometriosis, MCAS) | Covered by provincial plan + dietitian/specialist out-of-pocket variable | 2 to 6 months | High (standard of care for refractory) | Everyone meeting refractory definition. Always first. |
| Step 2a: Rifaximin (IBS-D) | Small bowel microbiota | $250 to $600 per 14-day course (variable insurance) | 4 to 12 weeks per trial | High (TARGET 3 RCTs) | IBS-D, suspected or confirmed SIBO |
| Step 2b: Eluxadoline (IBS-D) | Mu/delta opioid receptors | $150 to $300/month with insurance | 4 to 8 weeks | Moderate | IBS-D after rifaximin failure (contraindicated without gallbladder) |
| Step 2c: Linaclotide/plecanatide/lubiprostone (IBS-C) | Intestinal secretion + transit | $80 to $200/month with insurance | 4 to 8 weeks | High | IBS-C |
| Step 2d: Low-dose tricyclic | Visceral pain modulation | $5 to $30/month (often covered) | 6 to 12 weeks | High (ACG 2021 strong recommendation) | Pain-predominant IBS regardless of subtype |
| Step 3a: CBT for IBS | Symptom-related cognition, hypervigilance, behavioral avoidance | $1,200 to $2,400 (often partly covered by EHB psychology) | 8 to 12 weekly sessions | High (ACTIB 2019) | People with psychology coverage; cognitive-behavioral framework fit |
| Step 3b: Gut-directed hypnotherapy | Visceral hypersensitivity, gut-brain axis | $1,320 to $2,800 (ARCH-credentialed specialist) | 6 to 12 weekly sessions | High (NICE CG61, ACG 2021, Moser 2013 refractory RCT, Whorwell Manchester Protocol) | Visceral pain dominant, CBT non-responders, want different mechanism |
| Step 3c: MBSR/MBCT | Stress reactivity, mindfulness | $300 to $600 (8-week group) or free via hospital programs | 8 weeks | Moderate (Gaylord 2011, Zernicke 2013) | Budget-constrained; complement to other steps |
| Step 4: Integrative foundation (RDN low-FODMAP, sleep, exercise) | Triggers, autonomic regulation | $400 to $1,200 RDN + lifestyle changes | Ongoing | High for properly structured low-FODMAP (Peters 2016) | Always running underneath Steps 2 and 3 |
Wondering whether your nervous system is the kind that responds well to brain-gut behavioral therapies in the first place? Take our hypnotizability quiz, the result is one of the better predictors of which therapy in Step 3 will land for you.
2-Minute Self-Check
How hypnotizable are you?
Most people have no idea. Six quick questions will show you where you land.
6 questions · based on the Stanford & Tellegen clinical scales
Questions this page answers
What is the single best treatment for IBS when nothing else has worked?
There is no single best treatment. The honest answer is a sequenced escalation in four steps: (1) re-evaluate the diagnosis with a gastroenterologist to rule out missed conditions like bile acid malabsorption, microscopic colitis, pelvic floor dysfunction, MCAS, endometriosis, or celiac; (2) systematic prescription escalation appropriate to your subtype (rifaximin, eluxadoline, linaclotide, low-dose tricyclic); (3) one brain-gut behavioral therapy completed properly (CBT for IBS, gut-directed hypnotherapy, or mindfulness-based therapy); (4) integrative foundation (RDN-supervised low-FODMAP, sleep, exercise). NICE and ACG both endorse this general sequence.
Is gut-directed hypnotherapy actually evidence-based for refractory IBS?
Yes. NICE CG61 explicitly recommends hypnotherapy as a second-line option for IBS that has not responded to first-line treatment. The Moser 2013 RCT specifically enrolled refractory IBS patients and showed 40% clinically meaningful improvement in the hypnotherapy arm versus 13% in supportive talk therapy, with effects holding at 12 months. The Whorwell Manchester Protocol papers show sustained response in the 70 to 80% range in clinic populations. ACG 2021 gives a conditional recommendation. Read [Moser 2013 Vienna RCT breakdown](/articles/moser-2013-vienna-rct-breakdown) for the underlying trial.
Is hypnotherapy covered by insurance in Canada?
Hypnotherapy isn't directly covered by Canadian provincial health plans or most extended health benefit plans. Hypnotherapy isn't a regulated profession in Alberta. Some clients get reimbursement through their employer's Wellness Spending Account (WSA) under categories like 'stress management' or 'mental wellness'. WSAs are different from Health Spending Accounts (HSAs), which follow strict CRA medical-expense rules that exclude practitioners who aren't on a provincial regulated list. Always check with your specific plan whether RCH services qualify.
What if my GI says my IBS workup is complete and I just have to live with it?
A second opinion at an academic functional GI program is reasonable. Programs at University of Calgary GI, Toronto Western, McMaster, Mayo Clinic, or Cleveland Clinic specifically take complex refractory cases and often catch missed alternative diagnoses (bile acid malabsorption, microscopic colitis, pelvic floor dysfunction) that community gastroenterologists may not test for routinely.
I tried Nerva and it did not work. Does that mean gut-directed hypnotherapy did not work for me?
Not necessarily. The Nerva app delivers a fixed 6-week self-guided script. Roughly 9% of Nerva downloaders complete the full program in real-world data (Peters 2023). If you stalled before completion, you have not actually tested gut-directed hypnotherapy, you have tested a self-directed app. Clinician-led gut-directed hypnotherapy is personalized session-by-session, includes follow-up between sessions, and has much higher completion rates. The two are not equivalent. If you completed the full Nerva program and had no response, that is more meaningful evidence that GDH specifically may not be your answer, and CBT-IBS or another Step 3 option is worth trying.
How is CBT for IBS different from regular anxiety CBT?
CBT for IBS is a specialized form of CBT focused on the gut-brain axis. The work targets symptom-related thoughts, hypervigilance toward gut sensations, behavioral avoidance patterns specific to IBS (food avoidance, restroom mapping, social withdrawal), and stress management calibrated to gut symptoms. Generic anxiety CBT often does not address these specifically. The 2019 ACTIB trial (Everitt et al, Gut) is the landmark recent study. If you have done generic CBT and your gut symptoms did not improve, that does not mean CBT-IBS has been tried. Read [gut-directed hypnotherapy vs CBT for IBS](/articles/gut-directed-hypnotherapy-vs-cbt-for-ibs) for a deeper comparison.
Is rifaximin worth trying for refractory IBS?
Rifaximin is FDA-approved for IBS-D and is most useful when SIBO is suspected or confirmed. Response rates in the TARGET 3 trials were roughly 40 to 45% with sustained response in a subset. It is not appropriate for IBS-C. Cost varies with insurance coverage. Re-treatment is possible if symptoms recur. Have a focused conversation with your GI about whether your subtype and prior trials make rifaximin appropriate. We have a comparison at [hypnotherapy vs rifaximin for SIBO](/articles/hypnotherapy-vs-rifaximin-for-sibo) if SIBO is in your picture.
How do I know if I have actually done low-FODMAP properly?
A proper low-FODMAP trial is structured elimination for 2 to 6 weeks under the supervision of a registered dietitian with Monash low-FODMAP training, with careful symptom tracking, followed by systematic reintroduction of each FODMAP group to identify your specific triggers. Cutting out gluten and dairy for a while from a blog post is not low-FODMAP. Doing the elimination but never reintroducing is also not low-FODMAP. If your prior attempt was self-directed and unstructured, you have not actually tested low-FODMAP, and a proper trial with an RDN is reasonable before climbing to Step 3.
How many sessions of gut-directed hypnotherapy do I need?
The standard Manchester Protocol or North Carolina Protocol is 6 to 12 weekly sessions. Apps deliver a fixed 6-week program. ARCH-credentialed clinicians like Calgary Gut Hypnotherapy work on a 3-session commitment first ($660 to $1,050) to test response, then continue if the early signal is good. Most clients see meaningful change between sessions 4 and 8. See [how many sessions of gut-directed hypnotherapy](/how-many-sessions-of-gut-directed-hypnotherapy) for detail.
What if I have already tried CBT, hypnotherapy, AND prescription medications and nothing has worked?
Two paths. First, re-revisit Step 1 (diagnostic re-evaluation) at an academic functional GI program if you haven't, because some 'refractory IBS' really is a missed alternative diagnosis. Second, if Step 1 is genuinely thorough, a multidisciplinary functional GI program (University of Calgary, Toronto Western, Mayo, Cleveland Clinic, similar) that combines GI, psychiatry, psychology, dietetics, and pain medicine is the appropriate next step. These programs exist specifically for the most complex refractory cases and a referral from your GI can get you there.
I'm Danny M., a Registered Clinical Hypnotherapist (RCH) at Calgary Gut Hypnotherapy. Gut-directed hypnotherapy is one of the options in Step 3 of the escalation ladder above. If you have not yet completed Step 1 (GI re-evaluation), do that first. If you have, and you are in the brain-gut behavioral therapy zone, pick the option that fits your access and budget and complete a full protocol. ARCH-credentialed gut-directed hypnotherapy at Calgary Gut Hypnotherapy is $220 to $350 per session depending on complexity, 3-session commitment ($660 to $1,050), full protocol $1,320 to $2,800, capped intake, virtual across Canada or in person in Calgary. If after reading this article CBT-IBS or a different specialist is the right fit instead, that is the right call and I will say so on a consultation rather than upsell you into the wrong service.
Apply to work with us
We take on just 10 new clients a month. Apply below for an honest answer on whether hypnotherapy is the right fit — no packages, no pressure.
Only 2 spots left for May
About the Author
Danny M., Registered Clinical Hypnotherapist (RCH)
Danny is a Registered Clinical Hypnotherapist (RCH) with the Association of Registered Clinical Hypnotherapists of Canada (ARCH-Canada). At Calgary Gut Hypnotherapy he focuses on gut-directed hypnotherapy for IBS, SIBO, functional dyspepsia, and the gut-brain conditions hypnotherapy has the strongest track record with. Sessions run $220 to $350 each, structured around a 3-session commitment rather than open-ended therapy. Delivered fully online with clients across Canada and in-person in Calgary.
Learn more about our approachImportant: Hypnotherapy is a guided focused-attention practice, not medical care, not psychotherapy, and not a psychological treatment. Hypnotherapy is not a regulated health profession in any Canadian province, including Alberta. ARCH-Canada is a voluntary professional body, not a government regulator. Nothing on this site is medical advice, diagnosis, or treatment. Always consult your physician, gastroenterologist, or other licensed health professional for diagnosis, medication decisions, red-flag symptoms, or any medical concern. Hypnotherapy may complement medical care but never replaces it.